JDBRX
Price
$43.90
Change
+$0.30 (+0.69%)
Updated
Apr 25 closing price
Net Assets
25.08B
RLBEX
Price
$33.77
Change
+$0.13 (+0.39%)
Updated
Apr 25 closing price
Net Assets
230.79B
Ad is loading...

JDBRX vs RLBEX

Header iconJDBRX vs RLBEX Comparison
Open Charts JDBRX vs RLBEXBanner chart's image
Janus Henderson Balanced R
Price$43.90
Change+$0.30 (+0.69%)
VolumeN/A
Net Assets25.08B
American Funds American Balanced R4
Price$33.77
Change+$0.13 (+0.39%)
VolumeN/A
Net Assets230.79B
JDBRX vs RLBEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JDBRX vs. RLBEX commentary
Apr 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JDBRX is a Buy and RLBEX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RLBEX has more cash in the bank: 231B vs. JDBRX (25.1B). RLBEX pays higher dividends than JDBRX: RLBEX (1.97) vs JDBRX (1.40). JDBRX was incepted earlier than RLBEX: JDBRX (16 years) vs RLBEX (23 years). JDBRX (1.31) is less costly to investors than RLBEX (0.60). RLBEX is a more actively managed with annual turnover of: 171.00 vs. JDBRX (76.00). RLBEX has a lower initial minimum investment than JDBRX: RLBEX (250) vs JDBRX (2500). RLBEX annual gain was more profitable for investors over the last year : 4.87 vs. JDBRX (3.28). RLBEX (36.26) and JDBRX (35.32) have equivalent 5 years return.
JDBRXRLBEXJDBRX / RLBEX
Total Expense Ratio1.310.60218%
Annual Report Gross Expense Ratio1.310.60218%
Fund Existence16 years23 years-
Gain YTD-2.577-1.156223%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets25.1B231B11%
Annual Yield % from dividends1.401.9771%
Returns for 1 year3.284.8767%
Returns for 3 years14.4816.4688%
Returns for 5 years35.3236.2697%
Returns for 10 years57.2649.39116%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XAGE0.16N/A
+2.63%
Longevity Health Holdings Inc
VMEO5.200.06
+1.17%
Vimeo
NBIX106.730.97
+0.92%
Neurocrine Biosciences
EVO4.220.01
+0.24%
Evotec SE
CNF0.66N/A
+0.02%
CNFinance Holdings Limited